News
The U.K. Centre for Process Innovation (CPI), says a new blueprint will help biopharmaceutical firms navigate a digital ...
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible.
The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.
Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species for therapeutic applications.
Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in February.
Johanna Joyce, PhD, then took the rostrum and spoke eloquently on the tumor microenvironment, underscoring the immense ...
Senator Tammy Baldwin showed unwavering support for scientific funding when she accepted the AACR Distinguished Public Service Award.
GEN's Julianna LeMieux and IPM's Damian Doherty provide highlights of the first day of the AACR 2025 meeting in Chicago.
A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.
Integrating a cell line development capability into Cytiva’s biomanufacturing technologies could enhance a customer's ...
AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...
Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results